Adjuvant raises $300m for healthcare venture fund

Adjuvant Capital has raised $300 million for a venture capital fund that aims to accelerate the development of medicine for 'historically overlooked public health challenges'.

To access this article please sign-in below or register for a free one-month trial.

Forgot your password?

To access the premium content on Environmental Finance, you must first sign in to your account

Not registered? Take a free no obligation one-month trial.

Register for a trial